Sanofi SA (SNY)
49.25
+0.56
(+1.15%)
USD |
NASDAQ |
May 10, 16:00
49.25
0.00 (0.00%)
After-Hours: 20:00
Sanofi Market Cap: 122.95B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 121.55B |
| May 08, 2024 | 125.07B |
| May 07, 2024 | 123.75B |
| May 06, 2024 | 123.15B |
| May 03, 2024 | 122.35B |
| May 02, 2024 | 123.47B |
| May 01, 2024 | 124.90B |
| April 30, 2024 | 122.90B |
| April 29, 2024 | 122.55B |
| April 26, 2024 | 122.65B |
| April 25, 2024 | 123.22B |
| April 24, 2024 | 116.36B |
| April 23, 2024 | 119.06B |
| April 22, 2024 | 117.71B |
| April 19, 2024 | 115.59B |
| April 18, 2024 | 113.31B |
| April 17, 2024 | 115.11B |
| April 16, 2024 | 114.34B |
| April 15, 2024 | 115.44B |
| April 12, 2024 | 114.66B |
| April 11, 2024 | 116.33B |
| April 10, 2024 | 117.66B |
| April 09, 2024 | 118.66B |
| April 08, 2024 | 117.71B |
| April 05, 2024 | 117.96B |
| Date | Value |
|---|---|
| April 04, 2024 | 119.33B |
| April 03, 2024 | 119.73B |
| April 02, 2024 | 119.08B |
| April 01, 2024 | 120.55B |
| March 28, 2024 | 121.33B |
| March 27, 2024 | 123.67B |
| March 26, 2024 | 124.20B |
| March 25, 2024 | 123.42B |
| March 22, 2024 | 120.00B |
| March 21, 2024 | 119.16B |
| March 20, 2024 | 120.40B |
| March 19, 2024 | 118.53B |
| March 18, 2024 | 119.41B |
| March 15, 2024 | 120.55B |
| March 14, 2024 | 120.05B |
| March 13, 2024 | 120.43B |
| March 12, 2024 | 120.98B |
| March 11, 2024 | 120.70B |
| March 08, 2024 | 120.45B |
| March 07, 2024 | 119.98B |
| March 06, 2024 | 119.03B |
| March 05, 2024 | 118.58B |
| March 04, 2024 | 117.71B |
| March 01, 2024 | 118.06B |
| February 29, 2024 | 119.46B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
93.35B
Minimum
Sep 27 2022
143.50B
Maximum
Apr 11 2022
122.60B
Average
124.09B
Median
Dec 12 2019
Market Cap Benchmarks
| AstraZeneca PLC | 239.35B |
| GSK PLC | 91.90B |
| Regeneron Pharmaceuticals Inc | 107.19B |
| Cellectis SA | 220.90M |
| Denali Therapeutics Inc | 2.610B |
Market Cap Related Metrics
| PE Ratio | 24.89 |
| PS Ratio | 2.432 |
| Price to Book Value | 1.502 |
| Price | 49.25 |
| Earnings Yield | 4.02% |
| Operating PE Ratio | 11.58 |
| Normalized PE Ratio | 16.64 |